Upcoming Halozyme FDA Approvals/PDUFA dates:

• Ocrevus SC (Ocrelizumab SC),
September 13, 2024
• Tecentriq SC (Atezolizumab SC),
September 15, 2024

Don’t be surprised if we continue the run ahead of these 2 key catalysts.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174983569